logo

For the Inventor, By the Inventor

Jamison, PA, United States of America

Guodong Liu

This inventor holds 14 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Trevena, Inc., Trevana, Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guodong Liu. Retrieved from https://idiyas.com/inventor/guodong-liu-0lr1gxae

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.1

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2019)
  • Jamison, PA (US) (2014 - 2024)
  • Chesterbrook, PA (US) (2022 - 2024)

Company Filing History:

goldMedal13 out of 25 
 
Trevena, Inc.
 patents
silverMedal1 out of 1 
 
Trevana, Inc.
 patent

Years Active: 2014-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 11931350 - Opioid receptor ligands and methods of using and making same (2024-03-19),
2. 11912713 - 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2024-02-27),
3. 11912693 - Compounds for modulating S1P1 activity and methods of using the same (2024-02-27),
4. 11702408 - 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2023-07-18),
5. 11465980 - 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2022-10-11),
6. 11225487 - 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same (2022-01-18),
7. 11077098 - Opioid receptor ligands and methods of using and making same (2021-08-03),
8. 10588898 - Opioid receptor ligands and methods of using and making same (2020-03-17),
9. 10246436 - 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same (2019-04-02),
10. 9849119 - Opioid receptor ligands and methods of using and making same (2017-12-26),
11. 9642842 - Opioid receptor ligands and methods of using and making same (2017-05-09),
12. 9309234 - Opioid receptor ligands and methods of using and making same (2016-04-12),
13. 9044469 - Opioid receptor ligands and methods of using and making same (2015-06-02),
14. 8835488 - Opioid receptor ligands and methods of using and making same (2014-09-16),

Title: Guodong Liu: Innovator in Opioid Receptor Ligands

Introduction

Guodong Liu is a prominent inventor based in Jamison, PA (US), known for his significant contributions to the field of pharmaceutical sciences. With a total of 14 patents to his name, Liu has made remarkable strides in developing compounds that target opioid receptors and other related activities.

Latest Patents

Among his latest patents, Liu has developed compounds that act as opioid receptor ligands, which can be utilized in the treatment of pain and pain-related disorders. Another notable patent involves compounds for modulating S1P1 activity, which includes methods for using these compounds in pharmaceutical applications.

Career Highlights

Liu has worked with notable companies such as Trevena, Inc., where he has contributed to innovative research and development in the pharmaceutical industry. His work has focused on creating effective treatments for various medical conditions, particularly those related to pain management.

Collaborations

Throughout his career, Liu has collaborated with esteemed colleagues, including Philip Michael Pitis and Dennis Shinji Yamashita. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

Guodong Liu's contributions to the field of pharmaceutical sciences, particularly in opioid receptor ligands, highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of effective treatments for pain and related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…